These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33510858)

  • 41. Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells.
    Pin-Jung C; Pai-Chi T; Zhu Y; Jen Jan Y; Smalley M; Afshar Y; Li-Ching C; Pisarska MD; Hsian-Rong T
    Curr Obstet Gynecol Rep; 2019 Mar; 8(1):1-8. PubMed ID: 31565541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood.
    Zhang B; Lu BY; Yu B; Zheng FX; Zhou Q; Chen YP; Zhang XQ
    J Int Med Res; 2017 Apr; 45(2):621-630. PubMed ID: 28357876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and Economic Impact of Adopting Noninvasive Prenatal Testing as a Primary Screening Method for Fetal Aneuploidies in the General Pregnancy Population.
    Kostenko E; Chantraine F; Vandeweyer K; Schmid M; Lefevre A; Hertz D; Zelle L; Bartha JL; Di Renzo GC
    Fetal Diagn Ther; 2019; 45(6):413-423. PubMed ID: 30130800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M; Chaveeva P; Stratieva V
    Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent trends in prenatal genetic screening and testing.
    Pös O; Budiš J; Szemes T
    F1000Res; 2019; 8():. PubMed ID: 31214330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
    Bianchi DW; Chudova D; Sehnert AJ; Bhatt S; Murray K; Prosen TL; Garber JE; Wilkins-Haug L; Vora NL; Warsof S; Goldberg J; Ziainia T; Halks-Miller M
    JAMA; 2015 Jul; 314(2):162-9. PubMed ID: 26168314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.
    Zelig CM; Knutzen DM; Ennen CS; Dolinsky BM; Napolitano PG
    J Obstet Gynaecol Can; 2016 May; 38(5):441-445.e2. PubMed ID: 27261219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
    Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
    Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Optimized GATK4 Pipeline for Plasmodium falciparum Whole Genome Sequencing Variant Calling and Analysis.
    Niaré K; Greenhouse B; Bailey JA
    Res Sq; 2023 Feb; ():. PubMed ID: 36824880
    [No Abstract]   [Full Text] [Related]  

  • 51. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
    Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L
    Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of a fetal genotyping assay with potential for noninvasive prenatal diagnosis of hereditary hearing loss.
    Chen Y; Liu Y; Wang B; Mao J; Wang T; Ye K; Ye Y; Cram DS; Li H
    Prenat Diagn; 2016 Dec; 36(13):1233-1241. PubMed ID: 27862068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted fetal cell-free DNA screening for aneuploidies in 4,594 pregnancies: Single center study.
    Koc A; Ozer Kaya O; Ozyilmaz B; Kutbay YB; Kirbiyik O; Ozdemir TR; Erdogan KM; Saka Guvenc M; Oztekin DC; Ozeren M; Pala HG; Ekin A; Gezer C; Sahingoz Yildirim AG; Konuralp Atakul B; Kurtulmus S; Turhan U; Taner CE
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00678. PubMed ID: 31070015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
    Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uptake of noninvasive prenatal testing at a large academic referral center.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.
    Noh JJ; Ryu HM; Oh SY; Choi SJ; Roh CR; Kim JH
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):545-551. PubMed ID: 31307749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pilot study of a novel multi-functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single-gene disorder screening.
    Luo Y; Jia B; Yan K; Liu S; Song X; Chen M; Jin F; Du Y; Wang J; Hong Y; Cao S; Li D; Dong M
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00597. PubMed ID: 30767419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population.
    Li WH; Wang PH; Chuang CM; Chang YW; Yang MJ; Chen CY; Chao KC; Yen MS
    Taiwan J Obstet Gynecol; 2015 Apr; 54(2):122-5. PubMed ID: 25951714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
    Friel LA; Czerwinski JL; Singletary CN
    Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.